BETA

IPO registrations (S-1, F-1) · Registrants

Monopar Therapeutics

SEC CIK
1645469 · filings on EDGAR ↗
Registration
Form S-1, first filed 2019-08-15, last 2019-12-13; 1 initial registration, 6 amendments
Outcome
Final prospectus filed 2019-12-19; declared effective 2019-12-18
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
1000 SKOKIE BLVD SUITE 350, Wilmette, IL 60091
EIN
32-0463781
Ticker
MNPR (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
Monopar Therapeutics on the corporate pages

Offering terms

Proposed price range
$8.00–$10.00 per share (S-1/A filed 2019-12-13)
Final price
$8.00 per share, within the range (424B4 filed 2019-12-19, an initial public offering)
Shares sold
1,111,112
Gross proceeds
$8,888,896 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol MNPR
Lead underwriters
JonesTrading (833,334 shares)
Syndicate
Arcadia Securities, LLC (277,778)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 10

FiledFormWhat it isName as filedEDGAR
2019-08-15S-1S-1 (registration)Monopar Therapeutics0001654954-19-009689 ↗
2019-09-10S-1/AS-1/A (amendment)Monopar Therapeutics0001654954-19-010532 ↗
2019-09-13S-1/AS-1/A (amendment)Monopar Therapeutics0001654954-19-010692 ↗
2019-10-01S-1/AS-1/A (amendment)Monopar Therapeutics0001654954-19-011320 ↗
2019-11-04S-1/AS-1/A (amendment)Monopar Therapeutics0001654954-19-012323 ↗
2019-11-04S-1/AS-1/A (amendment)Monopar Therapeutics0001654954-19-012348 ↗
2019-12-13S-1/AS-1/A (amendment)Monopar Therapeutics0001654954-19-013910 ↗
2019-12-18EFFECTEFFECT (declared effective)Monopar Therapeutics9999999995-19-002848 ↗
2019-12-19424B4424B4 (final prospectus)Monopar Therapeutics0001654954-19-014106 ↗
2020-01-13EFFECTEFFECT (declared effective)Monopar Therapeutics9999999995-20-000083 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2019-12-13S-1/Aregistration statement$8.00–$10.001,111,112-Nasdaq MNPR1primary document; range, shares headlinedocument ↗
2019-12-19424B4final prospectus$8.001,111,112$8,888,896Nasdaq MNPR2primary document; price sentence, shares headline, proceeds table, underwriting table 2document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Anderson KirstenOfficerSVP, Clinical Development12018
Anderson RaymondDirector252018–2026
Brown Michael JDirector; Director,TenPercentOwner; Other262018–2025
Gem Pharmaceuticals LLCTenPercentOwner12018
Hendricks DianeTenPercentOwner32018–2025
KLAUSNER ARTHUR JDirector262018–2025
Leo KarlTenPercentOwner22018–2019
Mazar Andrew PaulDirector,Officer; Director,Officer,TenPercentOwnerChief Executive Officer; Chief Scientific Officer162018–2025
O'Halloran Thomas V.TenPercentOwner52018–2025
Pharma Investments LLCTenPercentOwner12018
RIOUX PATRICEOther112018–2026
Robinson ChandlerDirector,Officer; Director,Officer,TenPercentOwner; OtherChief Executive Officer402018–2026
STARR CHRISTOPHER MDirector242018–2025
TacticGem LLCTenPercentOwner22018–2024
Tactic Pharma LLCDirector,Officer,TenPercentOwner,Other; TenPercentOwnerChief Executive Officer; Chief Scientific Officer52018–2025
Tsuchimoto Kim RDirector; Director,Officer; OfficerChief Financial Officer282018–2026person page Fuzzy
Cittadine AndrewOfficerChief Operating Officer312021–2026
Filho Jose Octavio Pinto CostaOfficerChief Medical Officer22021
Radhakrishnan KarthikOfficerChief Financial Officer32024
Vu Quan AnhOfficerChief Financial Officer52025–2026
Talukdar LavinaDirector32025
Rodriguez SusanOfficerCCSO22026
Sweeny NicoleDirector22026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2017-08-23Monopar TherapeuticsBiotechnology$4,500,000$001
2017-03-28Monopar TherapeuticsBiotechnology$10,000,000$001
2016-03-15Monopar TherapeuticsBiotechnology$3,000,000$001
2015-06-18Monopar TherapeuticsBiotechnology$6,000,000$2,105,10081

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationMONOPAR THERAPEUTICS INC.ILState business registriesname and state
Business registrationMONOPAR THERAPEUTICS, INC.ILState business registriesname and state
Form D issuerMonopar TherapeuticsILForm D private offeringsCIK (EXACT)
Patent assigneeMonopar Therapeutics Inc.ILPatents (USPTO)name and state
SEC filerMonopar TherapeuticsSEC filers (EDGAR)CIK (EXACT)
Trademark ownerMonopar Therapeutics Inc.ILTrademarks (USPTO)name and state
Form 5500 plan sponsorMONOPAR THERAPEUTICS, INC.EIN (EXACT)
Person pageKim R TsuchimotoPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, IL first:

More with this interest.

In other datasets, the same topic (Health) in IL:

Interests: Pharmaceutical Preparations · Health